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Diabetes mellitus is a growing public health concern and a common chronic metabolic disease worldwide.1-4 Diabetes 
mellitus represents a group of metabolic diseases 
that are characterised by hyperglycaemia due to a 
total or relative lack of insulin secretion and insulin 
resistance or both. The metabolic abnormalities 
involve carbohydrate, protein and fat metabolism. 
Diabetes mellitus affects all age groups, but is more 
common in adults. The World Health Organization 
(WHO) has recently declared it to be a pandemic.2 
Its prevalence has increased dramatically over the 
past few decades and it is expected to triple in 
the next decade. Diabetes mellitus is considered 
a leading cause of death due to its microvascular 
and macrovascular complications.5,6  The most 
common types of diabetes are type 1 (also known 
as insulin dependent) and type 2 (also known 
as non-insulin-dependent).7,8 Type 2 is the more 
prevalent type. Countries with the highest rates 
of diabetes in the Eastern Mediterranean region 
and the Middle East are the United Arab Emirates, 
Saudi Arabia, Bahrain, Kuwait and Oman.9 Oman 
is one of the countries that has a high prevalence 
of diabetes mellitus, especially type 2 diabetes, and 
its prevalence is expected to increase in the next 
twenty years.10,11
Various inflammatory diseases and soft tissue 
pathologies in oral cavities are associated with 
diabetes mellitus;12-14 however, awareness of these 
complications is lacking worldwide.15-18 Periodontal 
diseases have been proposed as the sixth most 
prevalent complication of diabetes mellitus 
following the other diabetic complications.19 It has 
been reported as a more frequent oral complication 
of diabetes compared to other oral manifestations 
1Department of Oral Health, Sultan Qaboos University Hospital, Muscat, Oman; 2Department of Medicine, College of Medicine and 
Health Sciences, Sultan Qaboos University, Muscat, Oman.










aBstract: Diabetes mellitus is a chronic disease affecting all age groups. It is one of the leading causes of 
mortality and morbidity worldwide. Many chronic macrovascular and microvascular complications of diabetes 
have been reported in the literature with few reports about oral complications. This article aims to review and 
increase the awareness of oral manifestations and complications of diabetes mellitus and to stimulate research on 
the subject. It treats in depth some of the complications such as periodontal disease, fungal infection and salivary 
dysfunction while other complications are mentioned briefly.
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such as dry mouth and caries. Periodontitis is more 
frequent and severe in patients with diabetes with 
poor glycaemic control. Early identification and/or 
management of these oral manifestations may help 
in the early diagnosis of diabetes and in attaining 
better glycaemic control.20 Therefore, diabetic oral 
complications need to be identified and included 
in the ultimate care of diabetes in order to fight this 
chronic metabolic disease effectively.
Oral Complications and 
Manifestations of Diabetes 
Mell itus
Several soft tissue abnormalities have been reported 
to be associated with diabetes mellitus in the oral 
cavity. These complications include periodontal 
diseases (periodontitis and gingivitis); salivary 
dysfunction leading to a reduction in salivary 
flow and changes in saliva composition, and taste 
dysfunction. Oral fungal and bacterial infections 
have also been reported in patients with diabetes. 
There are also reports of oral mucosa lesions in 
the form of stomatitis,  geographic tongue, benign 
migratory glossitis, fissured tongue, traumatic 
ulcer, lichen planus, lichenoid reaction and angular 
chelitis.21-25 In addition, delayed mucosal wound 
healing, mucosal neuro-sensory disorders, dental 
carries and tooth loss has been reported in patients 
with diabetes.26 The prevalence and the chance of 
developing oral mucosal lesions were found to 





Periodontitis is one of the most widespread 
diseases in the world affecting the oral cavity, 
and is highly prevalent in both developed and 
developing countries.28 Periodontitis is a chronic 
inflammatory disorder affecting the gingivae and 
the periodontal tissue initiated by bacteria.29 The 
micro-flora in the dental plaque that forms daily 
adjacent to the teeth causes this inflammatory 
process. Eventually, the toxins that are released 
by the microorganisms in the dental plaque will 
start the gingival inflammation as a result of failure 
to remove the dental plaque on a daily basis. A 
periodontal pocket is formed as a result of the 
progression of the gingival inflammation causing 
the gingivae to detach from the tooth surface. 
This periodontal pocket is filled with bacteria 
and its toxins. As the disease worsens, the pocket 
will get deeper carrying the dental plaque until it 
reaches the alveolar bone that will eventually be 
destroyed with the periodontal attachment. This 
process is very common and causes destruction 
of periodontal tissues, loss of alveolar bone and, 
finally, tooth loss [Figure 1]. There are many 
factors contributing to this type of inflammation 
beside the presence of bacteria in dental plaque; a 
susceptible host is one of them.  
periodontitis and diabetes 
mellitus
The link between diabetes mellitus and periodontal 
disease is not well recognised by the medical 
community. Periodontal disease has been reported 
with increased prevalence and severity in patients 
with type 1 and type 2 diabetes.30 The mechanism 
by which hyperglycaemia can induce periodontal 
destruction is not yet fully understood. However, 
there are many theories which propose factors 
such as advanced glycation end products, 
changes in collagen statue, and altered immune 
function that causes impaired polymorphonuclear 
leukocyte function which may facilitate bacterial 
persistence in the tissue and the accumulation of 
advanced glycation end products, which results 
from prolonged and chronic hyperglycaemia and 
increased secretion of pro-inflammatory cytokines 
such as tumour necrosis factor-α and prostaglandin 
E-2.31,32 The increase in collagenase activity 
together with the reduction in collagen synthesis 
will adversely influence collagen metabolism. This 
Figure 1. Radiographic appearance of diabetic patient 
with sever periodontal destruction and bone loss.
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significant reduction in HbA1c.50 However, they 
also recommended that the results need to be 
viewed with caution due to a lack of strength and 
limitations in the designs of some of the studies 
included. Periodontitis and diabetes are related 
to each other therefore further larger studies are 
required to determine the effect of periodontal 
treatment on glycaemic control. 
Salivary and Taste 
Dysfunction
salivary dysfunction
Saliva has a major role in maintaining a healthy 
oral cavity. Saliva is produced by major salivary 
glands (parotid, sub-mandibular and sub-lingual) 
and numerous minor salivary glands distributed 
in the oral cavity. Salivary dysfunction has been 
reported in patients with diabetes.51,52 A cross 
sectional epidemiological study was conducted in 
2001 to look at the prevalence of hyposalivation 
and xerostomia (dry mouth) and to determine 
the relationship between salivary dysfunction and 
diabetes complications. This study was conducted 
in type 1 diabetics and control subjects without 
diabetes. They found that symptoms of reduced 
salivary flow rate and xerstomia were more 
frequently reported by patients with diabetes than 
the controls, especially by those diabetics who had 
developed neuropathy.53   Other studies conducted 
in type 2 diabetics also confirmed that xerostomia 
and hyposalivation were more prevalent in this 
group of patients.54 It has been shown that poorly 
controlled type 2 diabetics have a lower stimulated 
parotid gland flow rate compared to well-controlled 
patients and patients without diabetes.55 An 
increase in salivary pathogens was also reported 
in these patients.56 Patients with diabetes usually 
complain of xerostomia and the need to drink 
very often (polydypsia and polyuria). The constant 
dryness of the mouth would irritate the oral soft 
tissues, which in turn will cause inflammation 
and pain. Patients with diabetes with xerostomia 
are more predisposed to periodontal infection 
and tooth decay. The cause of this is not yet fully 
understood in patients with diabetes, but may be 
related to polydypsia and polyuria or alternation in 
the basement membrane of the salivary glands. It 
is known that diabetes mellitus is associated with 
would result in compromised wound healing as well 
as periodontal tissue destruction. Recent studies 
indicate that periodontitis has a bidirectional effect 
on glycaemic control in patients with diabetes.33 
There is a cluster of research studies, which support 
the hypothesis of periodontitis occurring more 
frequently in patients with diabetes with poor 
glycaemic control.33-38 In addition, there is enough 
evidence to support the hypothesis that poor 
periodontal conditions could worsen glycaemic 
control as well. Many studies report that diabetes 
is a risk factor for gingivitis and periodontitis and it 
is more severe with poor glycaemic control [Figure 
2].39 The risk of developing periodontitis in patients 
with diabetes has been reported to be three times 
higher than the general population.40
Numerous risk factors have been reported that 
make patients with diabetes more susceptible to 
periodontal disease, especially those with poor oral 
hygiene, poor metabolic control, longer duration 
of diabetes and who are smokers.41-43 Smoking 
was identified in many studies as being a major 
preventable risk factor for periodontal disease 
and tooth loss in the general population and in 
patients with diabetes.44-48 The dentist and the 
physician should play an important role in advising 
and supporting patients with diabetes regarding 
smoking cessation. The dentist should be engaged 
in counselling these patients and referring them to 
a specialist organisation which deals with smoking 
cessation.49
Several studies showed that the treatment of 
periodontal disease has an influence on glycaemic 
control in both type 1 and type 2. A recent meta-
analysis of the efficacy of periodontal treatment 
on glycaemic control in patients with diabetes 
suggested that such treatment could lead to a 
Figure 2. Clinical photograph showing periodontal 
abscess in poorly controlled diabetic patient. 
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chronic complications such as neuropathy, micro-
vascular abnormalities and endothelial dysfunction 
that lead to deterioration of microcirculation and 
this may play a role in reduction of the salivary 
flow rate and composition.57,58 Sialosis is defined as 
asymptomatic, non-inflammatory, non-neoplastic, 
bilateral chronic diffuse swelling mainly affecting 
the parotid glands. Sialosis has been found to be 
more prevalent in patients with diabetes mellitus.59 
taste dysfunction
There are many factors that have been implicated 
in altered taste sensation in the oral cavity. 
Metabolic and endocrine diseases were proposed 
as causative factors for this disturbance; 
nevertheless, salivary dysfunction can contribute 
to altered taste sensation or elevation of detection 
thresholds.60, 61 Taste dysfunction has been reported 
to occur more frequently in patients with poorly 
controlled diabetes compared to healthy controls.62 
Diabetic patients who suffer from neuropathy have 
a higher taste threshold. Taste disturbance has also 
been reported to lead to poor glycaemic control by 
inhibiting the ability to maintain a good diet.63 
Oral Infection
fungal infections
Oral candidosis is an opportunistic infection 
frequently caused by Candida albicans species. 
Many predisposing factors can lead to this 
infection; these include smoking, xerostomia and 
endocrine and metabolic diseases.64 Other factors 
were also implicated such as old age, medications, 
Cushing’s syndrome, malignancies, and the use of 
dentures.65 Oral candidosis has been classified into 
primary and secondary. Primary oral candidosis 
is subclassified into acute (pseudomembranous 
and erythematous), chronic (pseudomembranous, 
erythematous and hyperplastic) and candida 
associated lesions. 
Pseudomembranace candidosis is also known 
as oral thrush. It is characterised by the presence of 
a creamy white patch which, when wiped, reveals 
underlying erythematous and bleeding oral mucosa. 
The soft palate is the most commonly affected area 
followed by the cheek, tongue and gingivae. It could 
be chronic in immuno-compromised patients.66 
Erythematous candidosis can present as acute or 
chronic infection. It is believed to result from the 
usage of steroid and broad spectrum antibiotics 
and mainly affects the tongue.66 Hyperplastic 
candidosis is known as candidal leukoplakia. It 
appears as an irregular whitish raised plaque-
like lesion commonly seen in the buccal mucous 
membrane near the commissures. 
Candida associated lesions include denture 
induced stomatitis, angular chelitis and median 
rhomboid glossitis which have mixed bacterial 
and fungal etiology. Denture induced stomatitis 
is mainly seen in full denture wearers in the 
underlying surface of the upper denture. Angular 
chelitis is seen in the lip commissures as an 
erythematous crusting lesion. The lesion has been 
reported to occur in diabetics with poor glycaemic 
control. Median rhomboid glossitis is seen on 
the dorsal surface of the tongue as adepopulated 
erythematous diamond-shaped patch at the 
midline.
The incidence of fungal infections in patients 
with diabetes mellitus has been recognised for 
many years.67 Candidal infection is reported to be 
more prevalent in patients with diabetes especially 
in those patients who smoke, wear dentures, 
have poor glycaemic control and use steroids and 
broad spectrum antibiotics.68 In addition, salivary 
dysfunction in patients with diabetes can also 
contribute to higher carriage of fungi in this group 
of patients. It is clear from these studies that both 
local and systemic predisposing factors might 
increase candidal carriage rate and hence increase 
the risk of oral candidal infection in patients with 
diabetes.69-71
bacterial infections
Patients with diabetes are more susceptible to 
developing oral bacterial infections. They are well 
known to have an impaired defense mechanism 
hence considered to be immuno-compromised. 
Diabetics with diabetic complications and poor 
metabolic control are more prone to spreading 
and recurrent bacterial infection. Several studies 
have reported that patients with diabetes are 
more prone to deep neck bacterial infection 
compared to patient without diabetes.72,73 A four-
year prospective study by Rao et al. investigated 
the severity of maxillofacial space infection of 
odontogenic origin, the type of micro-organism, 
the sensitivity of the micro-organisms to 
Awatif Y Al-Maskari, Masoud Y Al-Maskari and Salem Al-Sudairy
review | 183
especially in type 1 diabetes. In addition, acute 
hyperglycaemia causes alteration in the immune 
responsiveness in diabetes mellitus. Atrophic-
erosive oral lesions are more common in patients 
with diabetes with OLP.77 
Neuro-Sensory Oral 
Disorder
Oral dysesthesia or burning mouth syndrome 
(BMS) is a painful condition affecting the oral 
cavity (palate, tongue, throat and gingivae).78,79 
Other abnormal oral sensations may co-exist with 
the burning mouth sensation such as tingling, 
numbness, dryness or sore mouth at the same time. 
The exact cause of BMS is unknown, but it has been 
attributed to several conditions such as dry mouth, 
menopause, candidal infection, diabetes mellitus, 
cancer therapy, psychological problems and acid 
reflux.  BMS is classified into two types: primary 
idiopathic, and secondary as a result of a systemic 
process; secondary BMS has been reported to 
occur with diabetes mellitus. It could adversely 
affect the ability to maintain good oral hygiene in 
patients with diabetes. Diabetic neuropathy could 
be the underlying cause of BMS in patients with 
diabetes.  The nerve damage in diabetic neuropathy 
has been reported to show an increase in the 
Langerhans cells that are associated with immune 
disturbance.80, 81 Therefore, it is crucial to screen 
patients who have symptoms of BMS for diabetes 
mellitus. 
Dental Caries and Tooth 
Loss
It is well known that patients with diabetes are 
susceptible to oral infections that lead to tooth 
decay and loss.82 Salivary secretion dysfunction, 
periodontal and sensory disorders could increase 
the likelihood of developing new and recurrent 
dental caries and tooth loss [Figure 3]. The 
relationship between diabetes and development 
of dental caries is still unclear.  It is well-known 
that the cleansing and buffering capacity of the 
saliva is diminished in patients with diabetes 
mellitus resulting in increased incidence of dental 
caries, especially in those patients who suffer from 
xerostomia.  
antibiotics, and the length of hospital stay of 
patients with diabetes compared with patients 
without diabetes. They concluded that the spread 
of the bacterial infection to the submandibular 
space was more common in patients and controls 
and that the second commonest area was the 
buccal space. Streptococcus species was more 
commonly isolated in both groups. Patients with 
diabetes were found to stay longer in hospital due 
to more severe infection and required more time to 
control their blood glucose levels.74
Poor Oral Wound Healing
Poor soft tissue regeneration and delayed osseous 
healing in patients with diabetes are known 
complications during oral surgery. Therefore, 
the management and treatment of patients with 
diabetes undergoing oral surgery is more complex. It 
was reported that delayed vascularisation, reduced 
blood flow, a decline in innate immunity, decreased 
growth factor production, and psychological stress 
may be involved in the protracted wound healing of 
the oral cavity mucosa in patients with diabetes.75
Non-Candidal Oral Soft 
Tissue Lesion
Oral lesions that are not caused by candidal 
infection have been reported to occur in patients 
with diabetes such as fissured tongue, irritation 
fibroma and traumatic ulcer. These lesions were 
more prevalent in diabetes compared to the 
controls.27 Altered or delayed wound healing may 
play a role in traumatic ulcer. 
Oral Mucosal Disease 
Both lichen planus and recurrent apthous 
stomatitis have been reported to occur in patients 
with diabetes.76,77 Oral lichen planus (OLP) is a skin 
disorder that produces lesions in the mouth. OLP 
is reported to occur more frequently in patients 
with type1 diabetes compared to type 2 diabetes.76 
The reason for this is that type 1 diabetes is 
considered an autoimmune disease, and OLP has 
been reported to have an underlying autoimmune 
mechanism. Patients with diabetes are subjected to 
a prolonged state of chronic immune suppression 
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Conclusion
Diabetes mellitus is a chronic, non-communicable 
and endemic disease. Type 2 compared to type 1 
diabetes mellitus is more prevalent worldwide and 
increasing, especially in Oman. Oral manifestations 
and complications in patients with diabetes mellitus 
have been recognised and reported recently as a 
major complication of diabetes mellitus. There is 
increasing evidence that chronic oral complications 
in patients with diabetes adversely affect blood 
glucose control. Prevention and management of 
oral complications, especially periodontal disease, 
in patients with diabetes is important due to their 
possible adverse effect on glycaemic control. 
Promotion of a healthy oral cavity in patients 
with diabetes is paramount. Epidemiological and 
research data on this problem in Omani patients 
with diabetes should be expanded by further studies. 
There are several clinical implications from this 
review. These include: 1) a lack of  awareness of oral 
complications among both diabetics and health 
providers; 2) an understanding of the way diabetes 
affects oral health is necessary for both clinicians 
and patients, therefore research in this field should 
be encouraged; 3) the need for regular follow-up of 
patients with diabetes mellitus by both dentist and 
physicians; 4) the major role that dentists should 
play in recognising the signs and symptoms of 
diabetes and their oral complications; 5) advice and 
counselling for diabetic smokers regarding smoking 
cessation, and 6) vigorous treatment of oral 
infection either bacterial or fungal in these patients, 
especially if they have poor glycaemic control.
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